Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02401685

POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer

POSNOC - POsitive Sentinel NOde: Adjuvant Therapy Alone Versus Adjuvant Therapy Plus Clearance or Axillary Radiotherapy. A Randomised Controlled Trial of Axillary Treatment in Women With Early Stage Breast Cancer Who Have Metastases in One or Two Sentinel Nodes

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,900 (actual)
Sponsor
University Hospitals of Derby and Burton NHS Foundation Trust · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

POSNOC is a pragmatic, randomised, multicentre, non-inferiority trial. Aim For women with early stage breast cancer and one or two sentinel node macrometastases, to assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years. Stratification: Institution, Age (\<50, ≥50), Breast-conserving surgery (BCS) or mastectomy, Estrogen receptor (ER) status (positive, negative), Number of positive nodes (1, 2), Intra-operative sentinel assessment using OSNA (yes, no). Interventions The study will compare adjuvant therapy alone with adjuvant therapy plus axillary treatment (axillary node clearance (ANC) or axillary radiotherapy (ART)). Sample Size: 1900 participants Follow-up: Participants will be followed up for 5 years. Adjuvant Therapy: All participants will receive adjuvant systemic therapy (chemotherapy and/or endocrine therapy). All participants may receive breast/chest wall radiotherapy. Axillary and supraclavicular fossa radiotherapy is not allowed when randomised to adjuvant therapy alone.

Conditions

Interventions

TypeNameDescription
OTHERAdjuvant therapyAdjuvant therapy will include chemotherapy and/or endocrine therapy for all women, and radiotherapy to breast or chest wall if indicated. Human epidermal growth factor receptor 2 (HER2) targeted treatment may also be administered when indicated.
PROCEDUREAxillary treatmentAxillary treatment can be axillary node clearance or axillary radiotherapy as per local guidelines.

Timeline

Start date
2014-08-01
Primary completion
2026-07-01
Completion
2026-12-31
First posted
2015-03-30
Last updated
2025-07-10

Locations

50 sites across 3 countries: Australia, New Zealand, United Kingdom

Source: ClinicalTrials.gov record NCT02401685. Inclusion in this directory is not an endorsement.